SCI & TECH● LOWAug 19 · Aug 19, 2026, 10:59 AM
Moderna, Merck rise after late-stage trial win for mRNA cancer therapy
Seeking Alpha Tech
Pharmaceutical companies Moderna and Merck saw their stock rise after a successful late-stage trial for their mRNA cancer therapy, indicating progress in cancer treatment and potential market impact.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH21m agoNew reality for China’s entertainment sector as AI drama goes prime timeSouth China Morning PostSCI & TECH1h agoAsia - Pacific SMEs seek new growth through AI , deeper connectivityaustraliannews.net · AustraliaSCI & TECH3h agoDGMA launches Seafarer Tracking Module on e - NAVIC portalmangalorean.com · IndiaSCI & TECH3h agoHere Why Everyone Hates AI Data Centers : An Explainer [ Op - Ed ] myk104.com · United States